18 October 2011
Brugada syndrome revealed by propafenone administration
Murat Turfan, Ethem Celik, Ender Ornek, Sani Namık Murat, Mustafa Duran, Muhammed Bora DemirCelikDOI: 10.12659/AJCR.882016
Am J Case Rep 2011; 12:122-124
Abstract
Abstract
Background: Brugada syndrome is an inherited cardiac disease characterized by high incidence of sudden death. We report the case of a 34-year-old man who was diagnosed with BS after propafenone administration for treatment of VT.
Case Report: A 34-year-old man presented to the emergency department with cardiac arrest. The patient was placed on a monitor that showed ventricular fibrillation and was quickly defibrillated. Afterward the patient had a run of ventricular tachycardia which was not hemodynamically destabilized. Intravenous propafenone was administrated, which achieved normal sinus rhythm. After this administration, a repeat ECG showed RBBB with ST segment elevation and the patient was referred to cardiology for suspected acute myocardial infarction. Then we immediately examined the patient and considered BS.
Conclusions: We report a case of BS revealed incidentally by use of propafenone. An acute myocardial infarction diagnosis was made erroneously in the emergency department. In addition, the emergency department physicians were unaware of propafenone usage to reveal a concealed BS. Emergency physicians should consider BS in patients with ECG pattern of this disease and they should consider propafenone usage as a pharmacological challenge test to induce ST segment elevation in the emergency department.
Keywords: Brugada syndrome, Propafenone, ventricular arrhythmia
In Press
Case report
Focal Autoimmune Pancreatitis Morphologically Mimicking Pancreatic Cancer: A Case Report and Literature ReviewAm J Case Rep In Press; DOI: 10.12659/AJCR.944286
Case report
Amyloidosis Found in the Breast: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.944755
Case report
Musculoskeletal Pain and Right Leg Paresthesia Revealed as Large Ovarian Mucinous Cystadenoma: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.945083
Case report
Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modif...Am J Case Rep In Press; DOI: 10.12659/AJCR.943936
Most Viewed Current Articles
07 Mar 2024 : Case report 41,616
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report 32,211
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
23 Feb 2022 : Case report 19,335
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
19 Jul 2022 : Case report 18,591
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128